| human | Q5 |
| P6178 | Dimensions author ID | 012377213515.43 |
| P496 | ORCID iD | 0000-0002-6603-6319 |
| P1153 | Scopus author ID | 57191874732 |
| P108 | employer | University of Jordan | Q610253 |
| Medical University of Vienna | Q700731 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q52569036 | A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer. |
| Q88883211 | A systematic review and meta-analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens |
| Q50062164 | Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder |
| Q52673351 | Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. |
| Q96581965 | An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer |
| Q90148014 | Association between Inflammatory Potential of Diet and Bladder Cancer Risk: Results of 3 United States Prospective Cohort Studies |
| Q57110451 | Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis |
| Q103822389 | Association of erectile dysfunction and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses |
| Q90043400 | Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization |
| Q52760819 | Caveolin-1 Expression in Upper Tract Urothelial Carcinoma. |
| Q50645475 | Characterization of Late Recurrence After Radical Cystectomy in a Large Multicenter Cohort of Bladder Cancer Patients. |
| Q93182737 | Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy |
| Q93220405 | Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study |
| Q64884209 | Comparison of perioperative complications and health-related quality of life between robot-assisted and open radical cystectomy: A systematic review and meta-analysis. |
| Q53059593 | Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. |
| Q91899065 | Current Disease Management of Primary Urethral Carcinoma |
| Q58603535 | Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma |
| Q100537058 | Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma |
| Q92009666 | Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis |
| Q91766029 | Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration |
| Q96814140 | Differential Impact of Gonadotropin-releasing Hormone Antagonist Versus Agonist on Clinical Safety and Oncologic Outcomes on Patients with Metastatic Prostate Cancer: A Meta-analysis of Randomized Controlled Trials |
| Q98237129 | Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer |
| Q100492519 | Does severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cause orchitis in patients with coronavirus disease 2019 (COVID-19)? |
| Q92204688 | Endocavitary treatment for upper tract urothelial carcinoma: A meta-analysis of the current literature |
| Q92873434 | Enhanced Recovery after Radical Cystectomy |
| Q91658935 | Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer |
| Q57186536 | External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis |
| Q47976852 | External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study |
| Q64076184 | Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis |
| Q48588271 | Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study |
| Q49508672 | Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. |
| Q92338808 | Impact of Gender on Chemotherapeutic Response and Oncologic Outcomes in Patients Treated With Radical Cystectomy and Perioperative Chemotherapy for Bladder Cancer: A Systematic Review and Meta-Analysis |
| Q38978287 | Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy. |
| Q91024343 | Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis |
| Q38988671 | Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer |
| Q92600989 | Incidence and survival outcomes in patients with upper urinary tract urothelial carcinoma diagnosed with variant histology and treated with nephroureterectomy |
| Q104462192 | Inflammatory bowel disease and prostate cancer risk: A systematic review |
| Q57163218 | Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients |
| Q52691240 | Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients. |
| Q52775564 | Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study. |
| Q39010863 | Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy. |
| Q28074930 | Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery |
| Q90552328 | Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes |
| Q50088923 | Novel endoscopic visualization techniques for bladder cancer detection: a review of the contemporary literature |
| Q38708787 | Obesity and its implications on nononcological urological surgery. |
| Q38708790 | Obesity and its implications on oncological urological surgery |
| Q38810626 | Obesity is associated with biochemical recurrence after radical prostatectomy: A multi-institutional extended validation study |
| Q49844303 | Oncologic Effect of Cumulative Smoking Exposure in Patients Treated With Salvage Radical Prostatectomy for Radiation-recurrent Prostate Cancer. |
| Q93047468 | Oncologic outcomes after robot-assisted versus open radical cystectomy: a systematic review and meta-analysis |
| Q120070257 | Oncological impact of cystoscopic findings in |
| Q91806154 | Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis |
| Q91131495 | Overactive bladder symptoms in patients undergoing rigid and flexible cystoscopy |
| Q49380161 | Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature. |
| Q92419683 | Performance of [68Ga] Ga-PSMA 11 PET for detecting prostate cancer in the lymph nodes before salvage lymph node dissection: a systematic review and meta-analysis |
| Q91428345 | Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis |
| Q50195455 | Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy |
| Q52763009 | Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma. |
| Q52589375 | Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence. |
| Q52951141 | Preoperative anemia is associated with disease recurrence and progression in patients with non-muscle-invasive bladder cancer. |
| Q92089720 | Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer |
| Q50278708 | Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer |
| Q38831584 | Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer. |
| Q90754536 | Prognostic Value of Concomitant Carcinoma In Situ in the Radical Cystectomy Specimen: A Systematic Review and Meta-Analysis |
| Q90643510 | Prognostic Value of Serum Cholinesterase in Non-muscle-invasive Bladder Cancer |
| Q52904959 | Prognostic role of N-cadherin expression in patients with non-muscle-invasive bladder cancer. |
| Q33840690 | Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study |
| Q89045833 | Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non-muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis |
| Q93128449 | Prognostic role of the urokinase plasminogen activator (uPA) system in patients with nonmuscle invasive bladder cancer |
| Q90726245 | Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer |
| Q90709729 | Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder |
| Q88600603 | Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer |
| Q93117728 | Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy |
| Q39046515 | Pure but Not Mixed Histologic Variants Are Associated With Poor Survival at Radical Cystectomy in Bladder Cancer Patients |
| Q49572949 | Robot-assisted partial nephrectomy: systematic review of functional results |
| Q90315155 | Role of serum cholinesterase in patients treated with salvage radical prostatectomy |
| Q91740836 | Second line immune checkpoint inhibition in urothelial cancer |
| Q96347391 | Stratification of Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: Implications for Adjuvant Therapies |
| Q91688664 | Surgical checklist impact on recurrence-free survival of patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumour |
| Q49486672 | Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer. |
| Q98501693 | The Association Between Personality Traits and Specialty Preference Among Medical Students in Jordan |
| Q46475608 | The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review |
| Q100492475 | The effectiveness of multiparametric magnetic resonance imaging in bladder cancer (Vesical Imaging-Reporting and Data System): A systematic review |
| Q94546542 | The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy |
| Q92264545 | The impact of gender on oncologic outcomes of bladder cancer |
| Q52715355 | The impact of moderate wine consumption on the risk of developing prostate cancer. |
| Q94476909 | The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration |
| Q52946591 | The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. |
| Q90627464 | The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC) |
| Q93128446 | The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review |
| Q104462196 | The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy |
| Q38936506 | Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy |
| Q100492546 | Ureteric stenting vs not stenting following uncomplicated ureteroscopic lithotripsy: A prospective randomised trial |
| Q52654653 | Waiting in the wings: the emerging role of molecular biomarkers in bladder cancer. |
| Q91104467 | What to do during Bacillus Calmette-Guérin shortage? Valid strategies based on evidence |
Search more.